In the context of intensified EU-Viet Nam relations, health represents an area in which enhanced bilateral cooperation could be bolstered. Partnering towards equitable pharmaceutical access in particular is a domain with high potential for achieving shared gains. These papers call for a collaborative partnership between institutions and stakeholders from the pharmaceutical sector, with the aim of guaranteeing equitable access to medicines to the Vietnamese people.
The papers present in-depth research on the state of Vietnam’s healthcare system, pharmaceutical industry and market, together with the role played by the EU and European pharmaceutical companies as Viet Nam’s partners for healthcare strengthening and expanded pharmaceutical access. In light of this research, recommendations are provided to the Vietnamese Government, the EU, Vietnamese and European pharmaceutical companies active in Viet Nam to jointly attain sustainable solutions to strengthen the healthcare system, and to improve availability, affordability and quality of medicines in the country – three pillars considered essential to achieve equitable access to medical drugs.
Author: Sara Bertucci, Associate ResearcherDownload Policy Brief